周辺タンパク質の品質管理は,プラズマ膜から展開されたCFTRを除去します
Tsukasa Okiyoneda1, Hervé Barrière, Miklós Bagdány
1Department of Physiology, and Groupe de Recherche Axé sur la Structure des Protéine (GRASP) McGill University, Montreal, Quebec H3G 1Y6, Canada.
まとめ
研究者らは,細胞表面で展開された性線維症トランスメブラン伝導性調節器 (CFTR) を退化させる周辺タンパク質品質管理システムを特定しました. このプロセスは,ユビキチネーションを含み,リゾソーム分解のために誤ったCFTRを標的とし,システィック線維症の治療戦略に影響を与えます.
科学分野:
- 細胞生物学 細胞生物学
- タンパク質の分解
- 分子医学は分子医学である.
背景:
- 胞性線維症は,CFTR遺伝子の変異によって引き起こされ,誤った折りたたまれたタンパク質の蓄積につながります.
- 治療戦略はCFTRの機能を回復することを目的としていますが,タンパク質の分解によって妨げられます.
- 細胞表面に誤ったCFTRが折りたたまれると,分解され,治療効果が制限されます.
研究 の 目的:
- 細胞表面における非原生CFTRの分解に起因するメカニズムを調査する.
- CFTRの除去に関与する周辺タンパク質の品質管理システムにおける主要なプレーヤーを特定する.
- このシステムが,システィック線維症の治療にどのように影響するかを理解する.
主な方法:
- 機能的な小干渉RNA (siRNA) スクリーンは,遺伝的成分を特定するために使用されました.
- ユビキチネーション経路の分析とCFTRの内部化と退化におけるその役割.
- チャペロン,コチャペロン,およびユビキチン結合酵素の貢献を調査した.
主要な成果:
- 細胞表面から展開されたCFTRを標的にする外周タンパク質品質管理システムが特定されました.
- 非原生CFTRのウビキチネーションは,その内部化およびその後のリソソーム分解に不可欠です.
- チャペロン,コチャペロン,およびユビキチン結合/結合酵素は,この除去プロセスを媒介することが判明しました.
結論:
- 細胞表面には外周タンパク質の品質管理システムがあり,誤ったCFTRを分解します.
- 非原生CFTRのユビキチン依存性ライソソーム性分解は,治療の成功を制限する重要な要因である.
- この経路を理解することは,システィック線維症の効果的な治療法の開発に不可欠です.
関連する概念動画
Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Molecular Chaperones and Protein Folding
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...


